Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications measuring nutrient reduction benefits policy analysis using linked non market valuation
… Market Access and Outcomes Strategy You need the right … therapeutic areas and phases of development. Strategy. Analysis. Solutions. We provide an integrated and … access strategies Disease area and portfolio strategies 2) Analysis: Understand Your Product's Value Once current market …
… etc.) Infectious disease models Linear, integer, and non-linear mathematical programming models Systematic and … and economic evidence Statistical analyses (survival analysis, multivariate regression, utility data analysis, … analysis Our Approach From design to deliverables, publications , and ongoing support, we develop and validate …
… Market Access and Evidence Generation Strategies At every … treatment pathway, epidemiology and unmet need A Gap Analysis Target Product Profile (TPP) Assessment A Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis Proven and Projected Value Assessments: Clinical, …
… Analysis of Heterogeneity of Treatment Effects for … pipeline. Stage-by-stage, this can help you: Stage Benefits Phase I - Identify and define unique responders … may have promising subgroup effects Methods & Applications Using innovative analytical methods based on structural …
… Conducting feasibility assessments for studies using databases and/or primary data collection Developing … study outlines, synopses and writing study protocols and analysis plans to use in regulatory discussions Advising on …
… Discrete Choice Experiments and Conjoint Analysis As a pharmaceutical or device manufacturer, your … to choose among treatment options with different sets of benefits and potential adverse events. Treatment attributes … state, disease progression, and available therapies, so market segments can emerge from these experiments. Below is …
… instrument is favored. The generally preferred method of measuring QALYs is to use quality-of-life or utility data. … Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee. Version 5.0 (PBAC, 2016) Belgium … de Chile, 2013); Kennedy-Martin et al. (2020) China No policy-generating agency Indirect utility methods such as …
Business Development and Marketing …
… Research Privacy Policy RTI Health Solutions (RTI-HS) takes your privacy … your Personal Information. This Research Privacy Policy (“Policy”) addresses what Personal Data may be … a business unit of RTI International, is an independent, non-profit research institute dedicated to improving the …
… In 2013, the European Medicines Agency evaluated the benefits and risks of cilostazol and recommended … decreased in all the study populations. The highest reduction was 57% in Catalonia. Prevalence of smoking before …